These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 22922304)
21. Identification and characterization of DNA imbalances in neuroblastoma by high-resolution oligonucleotide array comparative genomic hybridization. Scaruffi P; Coco S; Cifuentes F; Albino D; Nair M; Defferrari R; Mazzocco K; Tonini GP Cancer Genet Cytogenet; 2007 Aug; 177(1):20-9. PubMed ID: 17693187 [TBL] [Abstract][Full Text] [Related]
22. [The prognostic effect of amplification of the MYCN oncogene in neuroblastoma. The preliminary results of the Italian Cooperative Group for Neuroblastoma (GCINB)]. Pession A; De Bernardi B; Perri P; Mazzocco K; Rondelli R; Nigro M; Iolascon A; Forni M; Basso G; Conte M Pediatr Med Chir; 1994; 16(3):211-8. PubMed ID: 7971442 [TBL] [Abstract][Full Text] [Related]
23. An integrated 5-Mb physical, genetic, and radiation hybrid map of a 1p36.1 region implicated in neuroblastoma pathogenesis. Spieker N; Beitsma M; van Sluis P; Roobeek I; den Dunnen JT; Speleman F; Caron H; Versteeg R Genes Chromosomes Cancer; 2000 Feb; 27(2):143-52. PubMed ID: 10612802 [TBL] [Abstract][Full Text] [Related]
24. MYCN amplification and 17q in neuroblastoma: evidence for structural association. O'Neill S; Ekstrom L; Lastowska M; Roberts P; Brodeur GM; Kees UR; Schwab M; Bown N Genes Chromosomes Cancer; 2001 Jan; 30(1):87-90. PubMed ID: 11107180 [TBL] [Abstract][Full Text] [Related]
25. Cross-study analysis of gene expression data for intermediate neuroblastoma identifies two biological subtypes. Warnat P; Oberthuer A; Fischer M; Westermann F; Eils R; Brors B BMC Cancer; 2007 May; 7():89. PubMed ID: 17531100 [TBL] [Abstract][Full Text] [Related]
27. Distinct cytogenetic pathways of advanced-stage neuroblastoma tumors, detected by spectral karyotyping. Stark B; Jeison M; Bar-Am I; Glaser-Gabay L; Mardoukh J; Luria D; Feinmesser M; Goshen Y; Stein J; Abramov A; Zaizov R; Yaniv I Genes Chromosomes Cancer; 2002 Jul; 34(3):313-24. PubMed ID: 12007192 [TBL] [Abstract][Full Text] [Related]
28. Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma. Bown N; Cotterill S; Lastowska M; O'Neill S; Pearson AD; Plantaz D; Meddeb M; Danglot G; Brinkschmidt C; Christiansen H; Laureys G; Speleman F; Nicholson J; Bernheim A; Betts DR; Vandesompele J; Van Roy N N Engl J Med; 1999 Jun; 340(25):1954-61. PubMed ID: 10379019 [TBL] [Abstract][Full Text] [Related]
29. Rapid detection of MYCN gene amplification and telomerase expression in neuroblastoma. Hiyama E; Hiyama K; Yokoyama T; Fukuba I; Yamaoka H; Shay JW; Matsuura Y Clin Cancer Res; 1999 Mar; 5(3):601-9. PubMed ID: 10100712 [TBL] [Abstract][Full Text] [Related]
30. The 1p deletion is not a reliable marker for the prognosis of patients with neuroblastoma. Gehring M; Berthold F; Edler L; Schwab M; Amler LC Cancer Res; 1995 Nov; 55(22):5366-9. PubMed ID: 7585602 [TBL] [Abstract][Full Text] [Related]
31. Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study. Schmidt ML; Lal A; Seeger RC; Maris JM; Shimada H; O'Leary M; Gerbing RB; Matthay KK J Clin Oncol; 2005 Sep; 23(27):6474-80. PubMed ID: 16116154 [TBL] [Abstract][Full Text] [Related]
32. Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas. Guo C; White PS; Weiss MJ; Hogarty MD; Thompson PM; Stram DO; Gerbing R; Matthay KK; Seeger RC; Brodeur GM; Maris JM Oncogene; 1999 Sep; 18(35):4948-57. PubMed ID: 10490829 [TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of DNA di-tetraploidy in neuroblastoma. Ladenstein R; Ambros IM; Pötschger U; Amann G; Urban C; Fink FM; Schmitt K; Jones R; Slociak M; Schilling F; Ritter J; Berthold F; Gadner H; Ambros PF Med Pediatr Oncol; 2001 Jan; 36(1):83-92. PubMed ID: 11464912 [TBL] [Abstract][Full Text] [Related]
34. Identification of the genetic and clinical characteristics of neuroblastomas using genome-wide analysis. Uryu K; Nishimura R; Kataoka K; Sato Y; Nakazawa A; Suzuki H; Yoshida K; Seki M; Hiwatari M; Isobe T; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Koh K; Hanada R; Oka A; Hayashi Y; Ohira M; Kamijo T; Nagase H; Takimoto T; Tajiri T; Nakagawara A; Ogawa S; Takita J Oncotarget; 2017 Dec; 8(64):107513-107529. PubMed ID: 29296183 [TBL] [Abstract][Full Text] [Related]